You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API asenapine maleate


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing asenapine maleate

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Organon Pharmaceuticals USA SAPHRIS asenapine maleate 0052-0118 GELATIN
Organon Pharmaceuticals USA SAPHRIS asenapine maleate 0052-0118 MANNITOL
Allergan Inc SAPHRIS asenapine maleate 0456-2402 GELATIN
Allergan Inc SAPHRIS asenapine maleate 0456-2402 MANNITOL
Allergan Inc SAPHRIS asenapine maleate 0456-2402 SUCRALOSE
STAT RX USA LLC SAPHRIS asenapine maleate 16590-936 GELATIN
STAT RX USA LLC SAPHRIS asenapine maleate 16590-936 MANNITOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing asenapine maleate

Company Ingredient NDC Excipient
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359 ASPARTAME
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359 CELLULOSE, MICROCRYSTALLINE
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359 CROSPOVIDONE
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359 MAGNESIUM STEARATE
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359 POVIDONE K30
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359 SILICON DIOXIDE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for asenapine maleate

Excipient focus: ASPARTAME

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSPOVIDONE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

asenapine maleate drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Company Ingredient NDC
Organon Pharmaceuticals USA asenapine maleate 0052-0118
Allergan Inc asenapine maleate 0456-2402
STAT RX USA LLC asenapine maleate 16590-936
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359
Breckenridge Pharmaceutical Inc asenapine maleate 51991-361
Greenstone LLC asenapine maleate 59762-1091
Centaur Pharmaceuticals Private Limited asenapine maleate 64330-625
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: POVIDONE K30

Excipient focus: SILICON DIOXIDE

Excipient focus: SUCRALOSE

asenapine maleate drug variants not containing SUCRALOSE

Company Ingredient NDC
Organon Pharmaceuticals USA asenapine maleate 0052-0118
STAT RX USA LLC asenapine maleate 16590-936
Breckenridge Pharmaceutical Inc asenapine maleate 51991-359
Breckenridge Pharmaceutical Inc asenapine maleate 51991-361
Centaur Pharmaceuticals Private Limited asenapine maleate 64330-625
MSN LABORATORIES PRIVATE LIMITED asenapine maleate 69539-059
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group